Fidelity Disruptive Medicine ETF (FMED)
NASDAQ
Financial Services
Asset Management
$32.21
▲ +0.24%
Market Cap
$73.6M
Sector
Financial Services
Industry
Asset Management
Beta
0.78
52-Wk Range
23.48-32.89
CEO
—
Country
US
Currency
USD
Fidelity Disruptive Medicine ETF operates in the Asset Management industry of the Financial Services sector, headquartered in Boston, MA, US. The stock last traded at $32.21, up 0.24% on the session, giving a market capitalisation of $73.6M. Its beta of 0.78 implies it has historically moved less than the broad market.
Company profile
Exchange
NASDAQ Global Market
Employees
—
IPO date
2023-06-12
Headquarters
Boston, MA, US
About Fidelity Disruptive Medicine ETF
This exchange-traded fund allocates capital to pioneering enterprises reshaping medical detection, treatments, and care delivery, encompassing areas from genetic manipulation to automated surgical procedures and online health ecosystems.
Comparable companies
Fidelity Disruptive Medicine ETF is most often compared with the following Financial Services names:
More research on FMED
Open full interactive analysis & DCF →